1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Dysphagia Management Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Dysphagia Management Market Revenue and Volume Forecast, by Product Type
8.1.1. Drugs
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Feeding tubes
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Nutritional Solutions
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Others
8.1.4.1. Market Revenue and Volume Forecast
9.1. Dysphagia Management Market Revenue and Volume Forecast, by Indication
9.1.1. Oral Dysphagia
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Oropharyngeal Dysphagia
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Esophageal Dysphagia
9.1.3.1. Market Revenue and Volume Forecast
10.1. Dysphagia Management Market Revenue and Volume Forecast, by Age Group
10.1.1. Children
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Adults
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Geriatric
10.1.3.1. Market Revenue and Volume Forecast
11.1. Dysphagia Management Market Revenue and Volume Forecast, by End-User
11.1.1. Hospitals and Ambulatory Surgical Centers
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Homecare Settings
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Long-term Care Facilities
11.1.3.1. Market Revenue and Volume Forecast
11.1.4. Outpatient Clinics
11.1.4.1. Market Revenue and Volume Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Product Type
12.1.2. Market Revenue and Volume Forecast, by Indication
12.1.3. Market Revenue and Volume Forecast, by Age Group
12.1.4. Market Revenue and Volume Forecast, by End-User
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Product Type
12.1.5.2. Market Revenue and Volume Forecast, by Indication
12.1.5.3. Market Revenue and Volume Forecast, by Age Group
12.1.5.4. Market Revenue and Volume Forecast, by End-User
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Product Type
12.1.6.2. Market Revenue and Volume Forecast, by Indication
12.1.6.3. Market Revenue and Volume Forecast, by Age Group
12.1.6.4. Market Revenue and Volume Forecast, by End-User
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Product Type
12.2.2. Market Revenue and Volume Forecast, by Indication
12.2.3. Market Revenue and Volume Forecast, by Age Group
12.2.4. Market Revenue and Volume Forecast, by End-User
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Product Type
12.2.5.2. Market Revenue and Volume Forecast, by Indication
12.2.5.3. Market Revenue and Volume Forecast, by Age Group
12.2.5.4. Market Revenue and Volume Forecast, by End-User
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Product Type
12.2.6.2. Market Revenue and Volume Forecast, by Indication
12.2.6.3. Market Revenue and Volume Forecast, by Age Group
12.2.6.4. Market Revenue and Volume Forecast, by End-User
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Product Type
12.2.7.2. Market Revenue and Volume Forecast, by Indication
12.2.7.3. Market Revenue and Volume Forecast, by Age Group
12.2.7.4. Market Revenue and Volume Forecast, by End-User
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Product Type
12.2.8.2. Market Revenue and Volume Forecast, by Indication
12.2.8.3. Market Revenue and Volume Forecast, by Age Group
12.2.8.4. Market Revenue and Volume Forecast, by End-User
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Product Type
12.3.2. Market Revenue and Volume Forecast, by Indication
12.3.3. Market Revenue and Volume Forecast, by Age Group
12.3.4. Market Revenue and Volume Forecast, by End-User
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Product Type
12.3.5.2. Market Revenue and Volume Forecast, by Indication
12.3.5.3. Market Revenue and Volume Forecast, by Age Group
12.3.5.4. Market Revenue and Volume Forecast, by End-User
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Product Type
12.3.6.2. Market Revenue and Volume Forecast, by Indication
12.3.6.3. Market Revenue and Volume Forecast, by Age Group
12.3.6.4. Market Revenue and Volume Forecast, by End-User
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Product Type
12.3.7.2. Market Revenue and Volume Forecast, by Indication
12.3.7.3. Market Revenue and Volume Forecast, by Age Group
12.3.7.4. Market Revenue and Volume Forecast, by End-User
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Product Type
12.3.8.2. Market Revenue and Volume Forecast, by Indication
12.3.8.3. Market Revenue and Volume Forecast, by Age Group
12.3.8.4. Market Revenue and Volume Forecast, by End-User
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Product Type
12.4.2. Market Revenue and Volume Forecast, by Indication
12.4.3. Market Revenue and Volume Forecast, by Age Group
12.4.4. Market Revenue and Volume Forecast, by End-User
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Product Type
12.4.5.2. Market Revenue and Volume Forecast, by Indication
12.4.5.3. Market Revenue and Volume Forecast, by Age Group
12.4.5.4. Market Revenue and Volume Forecast, by End-User
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Product Type
12.4.6.2. Market Revenue and Volume Forecast, by Indication
12.4.6.3. Market Revenue and Volume Forecast, by Age Group
12.4.6.4. Market Revenue and Volume Forecast, by End-User
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Product Type
12.4.7.2. Market Revenue and Volume Forecast, by Indication
12.4.7.3. Market Revenue and Volume Forecast, by Age Group
12.4.7.4. Market Revenue and Volume Forecast, by End-User
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Product Type
12.4.8.2. Market Revenue and Volume Forecast, by Indication
12.4.8.3. Market Revenue and Volume Forecast, by Age Group
12.4.8.4. Market Revenue and Volume Forecast, by End-User
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Product Type
12.5.2. Market Revenue and Volume Forecast, by Indication
12.5.3. Market Revenue and Volume Forecast, by Age Group
12.5.4. Market Revenue and Volume Forecast, by End-User
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Product Type
12.5.5.2. Market Revenue and Volume Forecast, by Indication
12.5.5.3. Market Revenue and Volume Forecast, by Age Group
12.5.5.4. Market Revenue and Volume Forecast, by End-User
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Product Type
12.5.6.2. Market Revenue and Volume Forecast, by Indication
12.5.6.3. Market Revenue and Volume Forecast, by Age Group
12.5.6.4. Market Revenue and Volume Forecast, by End-User
13.1. AstraZeneca
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Bayer AG
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Pfizer, Inc
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Takeda Pharmaceutical Company Limited
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Dr Reddy's Laboratories Ltd.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Narang Medical Limited
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Advin Health Care
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Cardinal
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Abbott
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client